rs77707755

Variant summary

Our verdict is Benign. The variant received -16 ACMG points: 0P and 16B. BP4_StrongBP6_Very_StrongBS2

The NM_139319.3(SLC17A8):​c.354+16T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00399 in 1,613,734 control chromosomes in the GnomAD database, including 15 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.0037 ( 1 hom., cov: 31)
Exomes 𝑓: 0.0040 ( 14 hom. )

Consequence

SLC17A8
NM_139319.3 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: -0.594

Publications

0 publications found
Variant links:
Genes affected
SLC17A8 (HGNC:20151): (solute carrier family 17 member 8) This gene encodes a vesicular glutamate transporter. The encoded protein transports the neurotransmitter glutamate into synaptic vesicles before it is released into the synaptic cleft. Mutations in this gene are the cause of autosomal-dominant nonsyndromic type 25 deafness. Alternate splicing results in multiple transcript variants.[provided by RefSeq, May 2010]
SLC17A8 Gene-Disease associations (from GenCC):
  • nonsyndromic genetic hearing loss
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • autosomal dominant nonsyndromic hearing loss 25
    Inheritance: AD, Unknown Classification: STRONG, LIMITED Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae)
  • autosomal dominant nonsyndromic hearing loss
    Inheritance: AD Classification: SUPPORTIVE, LIMITED Submitted by: Labcorp Genetics (formerly Invitae), Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -16 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.88).
BP6
Variant 12-100380969-T-C is Benign according to our data. Variant chr12-100380969-T-C is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 262468.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS2
High AC in GnomAd4 at 560 AD,Unknown gene.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SLC17A8NM_139319.3 linkc.354+16T>C intron_variant Intron 2 of 11 ENST00000323346.10 NP_647480.1 Q8NDX2-1
SLC17A8NM_001145288.2 linkc.354+16T>C intron_variant Intron 2 of 10 NP_001138760.1 Q8NDX2-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SLC17A8ENST00000323346.10 linkc.354+16T>C intron_variant Intron 2 of 11 1 NM_139319.3 ENSP00000316909.4 Q8NDX2-1
SLC17A8ENST00000392989.3 linkc.354+16T>C intron_variant Intron 2 of 10 1 ENSP00000376715.3 Q8NDX2-2

Frequencies

GnomAD3 genomes
AF:
0.00367
AC:
559
AN:
152170
Hom.:
1
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.00432
Gnomad AMI
AF:
0.0165
Gnomad AMR
AF:
0.00183
Gnomad ASJ
AF:
0.00346
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00145
Gnomad FIN
AF:
0.00264
Gnomad MID
AF:
0.00949
Gnomad NFE
AF:
0.00410
Gnomad OTH
AF:
0.00383
GnomAD2 exomes
AF:
0.00306
AC:
767
AN:
251028
AF XY:
0.00301
show subpopulations
Gnomad AFR exome
AF:
0.00468
Gnomad AMR exome
AF:
0.00168
Gnomad ASJ exome
AF:
0.00208
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00305
Gnomad NFE exome
AF:
0.00427
Gnomad OTH exome
AF:
0.00261
GnomAD4 exome
AF:
0.00402
AC:
5877
AN:
1461446
Hom.:
14
Cov.:
31
AF XY:
0.00388
AC XY:
2818
AN XY:
727060
show subpopulations
African (AFR)
AF:
0.00571
AC:
191
AN:
33466
American (AMR)
AF:
0.00208
AC:
93
AN:
44720
Ashkenazi Jewish (ASJ)
AF:
0.00199
AC:
52
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00119
AC:
103
AN:
86232
European-Finnish (FIN)
AF:
0.00303
AC:
162
AN:
53420
Middle Eastern (MID)
AF:
0.00515
AC:
28
AN:
5442
European-Non Finnish (NFE)
AF:
0.00452
AC:
5031
AN:
1111976
Other (OTH)
AF:
0.00360
AC:
217
AN:
60354
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.476
Heterozygous variant carriers
0
289
578
867
1156
1445
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
198
396
594
792
990
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00368
AC:
560
AN:
152288
Hom.:
1
Cov.:
31
AF XY:
0.00342
AC XY:
255
AN XY:
74464
show subpopulations
African (AFR)
AF:
0.00433
AC:
180
AN:
41550
American (AMR)
AF:
0.00183
AC:
28
AN:
15308
Ashkenazi Jewish (ASJ)
AF:
0.00346
AC:
12
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00145
AC:
7
AN:
4822
European-Finnish (FIN)
AF:
0.00264
AC:
28
AN:
10616
Middle Eastern (MID)
AF:
0.0102
AC:
3
AN:
294
European-Non Finnish (NFE)
AF:
0.00410
AC:
279
AN:
68022
Other (OTH)
AF:
0.00379
AC:
8
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
31
62
92
123
154
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00309
Hom.:
0
Bravo
AF:
0.00411
Asia WGS
AF:
0.000577
AC:
2
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Jul 28, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Jan 20, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
-
PreventionGenetics, part of Exact Sciences
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.88
CADD
Benign
0.014
DANN
Benign
0.36
PhyloP100
-0.59
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs77707755; hg19: chr12-100774747; API